Cargando…
TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial
The aim of this study was to demonstrate the safety and effectiveness of a single TearCare procedure compared with a single LipiFlow procedure in treatment of the dry eye disease associated with meibomian gland dysfunction. METHODS: In a multicenter, masked, randomized controlled trial, 135 subjects...
Autores principales: | Gupta, Preeya K., Holland, Edward J., Hovanesian, John, Loh, Jennifer, Jackson, Mitchell A., Karpecki, Paul M., Dhamdhere, Kavita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cornea
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895971/ https://www.ncbi.nlm.nih.gov/pubmed/34581297 http://dx.doi.org/10.1097/ICO.0000000000002837 |
Ejemplares similares
-
A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease
por: Holland, Edward J, et al.
Publicado: (2022) -
A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare(®) System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
por: Karpecki, Paul, et al.
Publicado: (2020) -
TearCare(®) system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare(®) treatment on subjects with dry eye disease
por: Badawi, David
Publicado: (2019) -
A novel system, TearCare(®), for the treatment of the signs and symptoms of dry eye disease
por: Badawi, David
Publicado: (2018) -
Meibomian Gland Dysfunction: A Dermatological Perspective on Pathogenesis and Treatment Outlook
por: Gupta, Preeya K, et al.
Publicado: (2021)